U.S.
Department of Health and Human Services
Public Health Service
Non-Competing Continuation Progress Report (PHS 2590)
Instructions for PHS 2590
Revised 06/2009
Forms Approved Through 06/30/2012
OMB No. 0925-0001
TABLE OF CONTENTS
1. Continuation Progress Report 2
1.1 Continuation Progress Reports for Other PHS Agencies 2
1.2 Submission of Progress Report 3
1.3 Electronic Submission of SNAP Progress Reports (eSNAP) 3
1.4 GrantsInfo, DEOIR, OER, National Institutes of Health 4
1.6.1 DUNS
Registration for the Organization & Subaward/Consortium
Organizations 4
1.6.2 CCR Registration for the Organization 5
2. Preparing Progress Reports 5
2.1 NIH Streamlined Noncompeting Award Process (SNAP) 5
2.1.1 SNAP Instructions for Submitting the Progress Report 6
2.2.1 Face Page (non-SNAP awards only) 9
Item 5. Administrative Official 9
Item 7. Vertebrate Animals. 10
Item 8a. Direct Costs Requested for Next Budget Period 10
Item 8b. Total Costs Requested for Next Budget Period 10
Item 9. Inventions and Patents 10
Item 10. Project/Performance Sites 11
Item 11. Official Signing for Applicant Organization 11
Item 12: Face Page Corrections and Changes 11
Item 13. Applicant Organization Certification and Acceptance 12
2.2.2 Detailed Budget for Next Budget Period (non-SNAP awards only) 13
Consortium/Contractual Costs 15
2.2.3 Budget Justification (non-SNAP awards only) 15
2.2.4 Biographical Sketch (SNAP and non-SNAP awards) 16
2.2.5 Other Support (non-SNAP awards only) 17
2.2.6 Progress Report Summary (SNAP and non-SNAP awards) 17
F. Project-Generated Resources 24
2.2.7 Checklist (non-SNAP awards only) 24
Facilities and Administrative Costs 25
2.2.8 All Personnel Report (SNAP and non-SNAP awards) 25
3. Final Progress Report 26
4. General Information 27
4.1 Collection of Personal Demographic Data 27
4.2 Government Use of Information Under Privacy Act 28
4.3 Information Available to the Program Director(s)/Principal Investigator(s) (PD/PIs) 28
4.4 Information Available to the General Public 29
4.5 Access to Research Data 29
5. Additional
Instructions for Preparing Continuation Career Development Award
(CDA) Progress Reports 30
5.1.1 Detailed Budget for Next Budget Period (non-SNAP awards only) 30
5.1.2 Biographical Sketch (SNAP and non-SNAP awards) 30
5.1.3 Other Support (non-SNAP awards only) 30
5.1.4 Progress Report Summary (SNAP and non-SNAP awards) 30
I. Research Development and Other Activities Planned for the Next Year. 31
5.1.5 Study Subjects (SNAP and non-SNAP awards) 31
5.1.6 Checklist (non-SNAP awards only) 32
5.1.7 All Personnel Report (SNAP and non-SNAP awards) 32
6. Additional
Instructions for Preparing a Progress Report for an Institutional
Research Training Grant, Including Ruth L. Kirschstein
National Research
Service Awards 33
Item 9. Inventions and Patents 34
Item 13. Applicant Organization Certification and Acceptance 34
6.1.6 Progress Report Summary 36
Facilities and Administrative (Indirect) Costs 38
7. Additional
Instructions for Preparing a Progress Report for an SBIR and STTR
Award 40
Changes to the Instructions since 11/2007:
All Personnel Report (2.2.8) – Instruction updated to “List the PD/PI(s) and all personnel for the current budget period who participated on the project for one person month per year or more, regardless of source of compensation.” This update addresses a longstanding analytical need required by the PHS Act of 1974. Also, note it is now required that all individuals with a postdoctoral role with one person month or more of measurable effort on the project, must complete a one-time registration in the eRA Commons.
Revised NIH Public Access Policy implemented. See the 01/11/2008 NIH Guide Notice and NOT-OD-08-119 for additional information. Clarification of use of Data Tables 12A and 12B for the Non-competing NRSA's. (04/14/2008)
Implementation of NIH Reform Act of 2006 (P.L/ 109-482)
Table 12A, required for institutional research training applications, is modified to collect data on percentage of students who successfully attain a doctoral degree and average time to receive a doctoral degree.
A new Graduate Student Assurance, that this same information is provided to students applying to graduate programs, is required as applicable.
Progress Report Summary (2.2.6 B) As part of the Enhancing Peer Review Initiative, PD/PIs are asked, if applicable, to address any changes to the innovative potential of the project.
Changes to specific form and format pages:
All Personnel Report Page – Revised to collect information on the PD/PIs and all personnel, added column to collect the eRA Commons user ID, and month and year of birth.
Progress Report Summary - A new item, E. Human Embryonic Stem Cell Line(s) Used is provided for grantees to indicate any changes to research involving hESCs, including use of different cell lines.
Progress reports are required to continue support of a PHS grant for each budget year within a competitive segment. The PHS 2590 can be used for more frequent reporting requirements such as interim reporting and for Multi-Year Funded Awards. Instructions for submitting a Final Progress Report, required for any grant that is terminated, are found in Section 3. For more information on the PHS 2590, contact Grants Information at [email protected] or call 301-435-0714.
For NIH awards issued under the Streamlined Noncompeting Award Process (SNAP), the progress report must be submitted electronically through the eRA Commons electronic SNAP (eSNAP) module 45 days before the beginning date of the next budget period.
All NIH progress reports for non-SNAP awards must be submitted in hard copy to the centralized mailing address below, two months before the beginning date of the next budget period:
Division of Extramural
Activities Support, OER
National Institutes of Health
6705
Rockledge Drive, Room 2207, MSC 7987
Bethesda, MD
20892-7987 (for regular or US Postal Service Express mail)
Bethesda, MD 20817 (for other courier/express mail
delivery only)
Phone Number: (301) 594-6584
Note that throughout these instructions are references to “competing application instructions.” “Competing application instructions” means either the SF424 (R&R) Application Guides (http://grants.nih.gov/grants/funding/424/index.htm), or the PHS 398 Grant Application (http://grants.nih.gov/grants/funding/phs398/phs398.html).
While other PHS awarding agencies use these same progress report forms, some may have application requirements that are different from those for NIH grantees. For agency specific instructions for AHRQ, CDC, FDA and IHS, refer to the terms and conditions of the Notice of Award (NoA) or their website listed in the table below.
References to the NIH Grants Policy Statement (NIHGPS) throughout these instructions apply only to NIH and not to the other PHS awarding agencies. The agencies listed below follow the Department of Health and Human Services Grants Policy Statement (HHSGPS) as their awarding guidance (http://www.hhs.gov/asfr/ogapa/grantinformation/hhsgps107.pdf).
301-427-1447 |
|
1-800-232-4636 |
|
301-443-0578 |
|
301-827-7185 |
NIH grantees can determine which progress reports are due through the website located at: http://era.nih.gov/ userreports/pr_due.cfm. NIH grantees are responsible for periodically checking the list, which is updated on/around the 30th of each month. In addition to this website, automatic e-mail notifications are sent to the PD/PI.
Progress report due dates are also available in the eRA Commons Status system. For more information on the Commons, see: https://commons.era.nih.gov/commons/index.jsp.
Additional instructions for preparing continuation progress reports for Career Development Awards are found in Section 5; additional instructions for preparing progress reports for Institutional Research Training Awards are found in Section 6; additional instructions for preparing a progress report for an SBIR and STTR award are found in Section 7.
If submitting electronically via eSNAP, only the Signing Official/authorized organization representative (SO/AOR) may submit to NIH unless the SO has assigned eSNAP submission rights to the PD/PI through the eRA Commons eSNAP Delegate Submit authority function.
If submitting hard copy (non-SNAP awards), grantees are required to submit the completed, signed original progress report. Copies are not necessary. Do not bind or staple the original. You may substitute computer-generated facsimiles for any of the forms. Substitute forms should be printed in black ink, and maintain the exact wording and format of the government-printed forms, including all captions and spacing. Any questions on completing this continuation progress report should be directed to the awarding component. The forms, in Adobe Acrobat and Microsoft Word, can be downloaded from the NIH web site at http://grants.nih.gov/grants/forms.htm.
Use English only and avoid jargon. If terms are not universally known, spell out the term the first time it is used and note the appropriate abbreviation in parentheses. The abbreviation may be used thereafter. Prepare the progress report single-sided and single-spaced. NIH requires the use of Arial, Helvetica, Palatino Linotype or Georgia typeface, a black font color and a font size of 11-points or larger. A symbol font may be used to insert Greek letters or special characters; the font size requirement still applies. These fonts will conform to appropriate formatting specifications. The progress reports must be clear and readily legible. Figures, charts, tables, figure legends, and footnotes may be smaller in size but must be black ink, readily legible, and follow the font typeface requirement.
An incomplete or incorrectly prepared continuation progress report may result in a delay in award of funds.
Reminder: Review and update your eRA Commons Personal Profile as necessary.
Progress reports for awards issued under the SNAP (Streamlined Noncompeting Award Process) provisions due August 1, 2010 and thereafter must be submitted electronically through the eRA Commons eSNAP module. eSNAP provides grantees the ability to enter data into forms as well as upload files for the progress report and other supporting documentation. For more information on eSNAP, visit the eRA Commons at: https://commons.era.nih.gov/ commons/index.jsp.
When using eSNAP to electronically prepare and submit a progress report, do not use the PHS 2590 fillable form pages for any file uploads. Text inserted into the fillable form pages is not saved once the progress report is submitted to NIH. Guidance on eSNAP submission is documented in the eSNAP User Guide found at: http://era.nih.gov/docs/eSNAP_UG_v2.25.0.0_041210.pdf. Questions on eSNAP submission should be directed to:
Email the Commons Help Desk at [email protected].
Call the Commons Help Desk at 1-800-504-9552 (toll-free) or 301-402-7469; 301-451-5939 (TTY). Business hours are M-F 7am-8pm Eastern Time.
AHRQ, CDC, FDA and IHS do not participate in the eSNAP process.
The Division of Extramural Outreach and Information Resources (DEOIR) provides general information about NIH extramural research and research training programs, funding mechanisms, the peer review system, and progress report procedures. The NIH grants Web site is at http://grants.nih.gov/grants/oer.htm. The e-mail address is: [email protected]. The phone number is (301) 435-0714.
PHS estimates that it will take approximately 15 hours to complete this progress report. Items such as human subjects are cleared and accounted for separately, and are not part of the time estimate for completing this form. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. If you have comments regarding the burden estimate or other aspect of the collection of information, including suggestions for reducing the burden, send comments to: NIH, Project Clearance Office, 6705 Rockledge Drive MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0001). Do not send progress reports to this address.
A Data Universal Numbering System (DUNS) number is required for all progress reports-paper and electronic-and must be obtained prior to submission. For organizations that already have multiple DUNS numbers, one DUNS number should be selected by an AOR and used consistently for all submissions. The AOR should be consulted to determine the appropriate number to use.
The DUNS number is considered the Federally-recognized unique identifier and is used for reporting purposes, particular those associated with the Federal Financial Assistance Transparency Act (FFATA) of 2006 (P.L. 109-282).
FFATA also includes a requirement for reporting on subaward information. Therefore an accurate DUNS number for each additional subaward/consortium organization must also be provided.
Additional information on DUNS registration is found at: http://fedgov.dnb.com/webform/displayHomePage.do.
A DUNS number is required for Central Contractor Registration (see 1.6.2 below).
Prior to submission of all progress reports-paper and electronic-organizations are required to be registered in the Central Contractor Registration (CCR). Organizations must maintain the currency of the information in the registry and renew the registration annually. A DUNS number is required for CCR registration.
CCR is a government-wide registry for organizations doing business with the U.S. Government. The registry collects, validates, stores, and disseminates data in support of agency acquisition missions, including Federal agency contract and assistance awards. The CCR registry will be used by Federal agencies to validate the DUNS number provided. Validation of the DUNS number will be critical for agencies to comply with the requirements of the Federal Financial Assistance Transparency Act (FFATA) of 2006 (P.L. 109-282).
Organizational information entered into the CCR must match that in the eRA Commons. Since CCR Registration can take several days to complete, the process should be started well in advance of a submission date to avoid potential delays. An AOR should be consulted to determine if the organization has properly completed and maintained CCR registration. Additional information on CCR registration is found at: http://www.ccr.gov/.
For submission of SNAP progress reports, follow the instructions under Section 2.1 below.
For submission of non-SNAP progress reports, follow the instructions under Section 2.2 below, using the fillable PHS 2590 Forms posted at http://grants.nih.gov/grants/funding/2590/2590.htm. These instructions are applicable to grantees of AHRQ, CDC, FDA and IHS which do not participate in the SNAP process.
SNAP is a streamlined process for the submission of information prior to the issuance of a noncompeting award. When the SNAP procedures apply, the progress report must be submitted electronically using the eSNAP module in eRA Commons. Grantees should refer to their Notice of Award, Terms and Conditions to determine whether SNAP procedures apply. In general, these streamlined instructions apply to all R series grant activity codes except for Outstanding Investigator Grants (R35s), Phase 1 Small Business Innovation Research Grants (R43) and Phase 1 Small Business Technology Transfer Grants (R41). For Phase I SBIR/STTR awards that exceed one year and Phase II SBIR/STTR, grantees should review the Notice of Award to determine if their project is subject to, or excluded from, the SNAP provisions. Career award activity codes (Ks) are routinely covered under SNAP. Those activity codes routinely excluded from SNAP are generally those that do not have the authority to automatically carry over unobligated balances: centers, cooperative agreements, institutional training (including Kirschstein-NRSA grants), non-Fast Track Phase I SBIR and STTR awards, clinical trials (regardless of activity codes), Program Project Grants (P01s) and Outstanding Investigator Grants (R35s). All NIH award notices identify whether the grant is subject to, or excluded from, SNAP.
An eSNAP is accessed by logging into the eSNAP Module via the eRA Commons. The Manage eSNAP screen will display a list of all assigned awards. Those that are eligible for eSNAP submission are displayed with an eSNAP hypertext link. Clicking the link will provide the user with access to the eSNAP progress report.
The 7 parts of an eSNAP are listed below with references to the appropriate PHS 2590 instruction. You will find these sections listed on the Manage eSNAP page with an indication of the status of each (complete or incomplete).
Upload Science – provides for 4 PDF uploads:
Progress Report File: Follow the instructions in Section 2.2.6 Progress Report Summary,
Research Accomplishments File: Ignore this upload unless specifically directed by the Program Officer to provide it.
Other File: this is the appropriate place to upload additional information that may be necessary, e.g., bibliographical sketch for new senior/key personnel,
Cover Letter: a cover letter is not required but may be provided if necessary.
The Upload Science screen is also where Publication Information is displayed and reported.
Org Information (part of eSNAP Edit Business tab) - edit or update the organization information as appropriate.
Project/Performance Sites (part of eSNAP Edit Business tab) - edit or update the project/performance site list as appropriate.
All Personnel List (part of eSNAP Edit Business tab) - refer to Section 2.2.8 All Personnel Report.
Research Subject (part of eSNAP Edit Business tab) - refer to Section 2.2.6, D.
SNAP and Other Progress Report Questions & Checklist (part of eSNAP Edit Business tab) The following questions appear on this screen; references to the appropriate PHS 2590 instructions are included here:
Has there been a change in the other support of Senior/Key Personnel since the last reporting period? See Section 2.1.2 SNAP Questions.
Will there be, in the next budget period a significant change in the level of effort for the PD/PI or other Senior/Key Personnel designated on the Notice of Award from what was approved for this project? See Section 2.1.2 SNAP Questions.
Is it anticipated that an estimated unobligated balance (including prior year carryover) will be greater than 25% of the current year's total approved budget? See Section 2.1.2 SNAP Questions.
Change in Select Agent Research? See Section 2.2.6, D.
Change in Multi PD/PI Leadership Plan? See Section 2.2.6, D.
Change in human embryonic stem cell (hESC) line(s) used? See Section 2.2.6, D.
Were any inventions conceived or first actually reduced to practice during the course of work under this project? Refer to the non-SNAP instruction at Section 2.2.1 Face Page, item 9.
Is program income anticipated during the proposed period for which support is requested? Refer to the non-SNAP instruction in Section 2.2.7 Checklist, Program Income.
Change in the Performance sites that will affect F&A costs, if applicable. Refer to the non-SNAP instruction in Section 2.2.1 Face Page, item 10.
Inclusion Enrollment (part of eSNAP Edit Business tab) – See Section 2.2.6, D.
All applicable parts must be complete in order to route the eSNAP to an eSNAP reviewer at the grantee organization, and to NIH.
Assurances/Certifications
In submitting an eSNAP, the SO (or PD/PI with delegated authority), certifies that the grantee organization will comply with all applicable assurances and certifications listed in Part III of the competing application instructions, and is responsible for verifying the accuracy, validity, and conformity with the most current institutional guidelines of all the administrative, fiscal, and scientific information in the progress report. Deliberate withholding, falsification, or misrepresentation of information could result in administrative actions, such as withdrawal of a progress report, suspension and/or termination of an award, debarment of individuals, as well as possible criminal penalties. The SO (or PD/PI with delegated authority) further certifies that the applicant organization will be accountable both for the appropriate use of any funds awarded and for the performance of the grant-supported project or activities resulting from the progress report. The grantee institution may be liable for the reimbursement of funds associated with any inappropriate or fraudulent conduct of the project activity.
The following questions appear on the Edit Business – SNAP and Other Progress Report Questions & Checklist screen:
Has there been a change in the other support of senior/key personnel since the last reporting period?
If yes, explain the change(s); if no, so state. Specific information is to be provided only if active support has changed, or if new senior/key personnel are added to the project. If a previously active grant has terminated and/or if a previously pending grant is now active, submit complete Other Support information using the suggested format and instructions found in the competing application instructions. Annotate this information so it is clear what has changed from the previous submission. Submission of other support information is not necessary if support is pending or for changes in the level of effort for active support reported previously.
Other support information should be submitted only for the PD/PI and for those individuals considered by the PD/PI to be key to the project. Senior/key personnel are defined as individuals who contribute in a substantive measurable way to the scientific development or execution of the project, whether or not a salary is requested. Do not routinely include Other Support information for Other Significant Contributors; e.g., those that may contribute to the scientific development or execution of the project, but are not committing any specified measurable effort to the project. However, if the level of involvement for an individual previously listed in this category has changed such that they are now considered senior/key personnel, this change should be indicated in this section and Other Support information submitted.
Will there be, in the next budget period, a significant change in the level of effort for the PD/PI(s) or other senior/key personnel designated on the Notice of Award from what was approved for this project?
If yes, please explain (e.g., decreased level of effort from 4.8 calendar year (CY) months to 3.6 CY months); if no, so state. A significant change in level of effort is defined in Federal regulations as a 25 percent reduction in time devoted to the project, from what was approved at the time of award. For example, if a NoA-specified individual on the project is expected to reduce his/her effort from 4.8 CY months to 3.6 CY months, which represents a 25 percent reduction in the level of effort, an explanation must be provided.
Is it anticipated that an estimated unobligated balance (including prior year carryover) will be greater than 25 percent of the current year's total approved budget?
If yes, please provide an explanation; if no, so state. An explanation should include why there is a significant balance and how it will be spent if carried forward into the next budget period. The “total approved budget” equals the current fiscal year award authorization plus any carryover of funds from a prior year. The numerator equals the total amount available for carryover and the denominator equals the current year’s total approved budget.
Program or grants management staff may require additional information in order to evaluate the project for continued funding. Failure to provide this information will result in a delayed award.
If you have any questions, contact the grants management specialist identified on the current Notice of Award.
The computer-generated Face Page available in the eRA Commons has information already prepopulated through Item 5. Complete and use this as the final copy. Add the electronic mail address information, if applicable. Check the preprinted material carefully and, when necessary, make corrections by entering the item number and the correct information under Item 12. Do not use Item 12 to indicate change of applicant organization. Form PHS 398 must be used in such cases. Contact the awarding component for further instructions.
Note: If the preprinted copy is not provided, or extensive corrections are necessary, use PHS 2590 Form Page 1, which is available at http://grants.nih.gov/grants/funding/2590/2590.htm.
Multiple PD/PIs: If multiple PD/PIs are part of the NIH approved project, use the Face Page-Continued page to provide items 2a – 2e for all PD/PIs. NIH requires one PD/PI be designated as the “contact PD/PI.” This individual should be listed in block 2a of the Face Page with all additional PD/PIs listed on the Face Page - Continued.
If this progress report submission includes a change in the contact PD/PI, include the name and contact information for the new contact PD/PI in Section 2a of the Face Page (Form Page 1). Note this change in Section 12 of the Face Page. All other PD/PIs should be listed using the Face Page-continued page. Also address this change in the Progress Report Summary by indicating a Change in the Multiple PD/PI Leadership Plan. Remember, the designated contact PD/PI must be from the grantee institution if PD/PIs are from more than one Institution.
If the institutional representative to be contacted for additional information has changed, make the necessary corrections in Item 12 on the computer-generated Face Page.
Policy on research involving human subjects can be found in the NIH Grants Policy Statement or the competing application instructions. Guidance pertaining to Human Subjects Research, including clinical trials and NIH-Defined Phase III Clinical Trials, may be found in Part II of the competing application instructions. Human subject definitions are found in Part III of the competing application instructions. Check "No" if activities involving human subjects are not planned at any time during the proposed budget period. The remaining parts of Item 6 are then not applicable.
Check "Yes" if activities involving human subjects are planned at any time during the budget period, either at the applicant organization or at any other project/performance site or collaborating institution. “Yes” should be checked even if the research is exempt from HHS regulatory requirements for the protection of human subjects.
Appropriately designating whether human subjects are involved may facilitate processing of an award. Information about how the regulations apply to the proposed research may be obtained from the Office for Human Research Protections (OHRP), Department of Health and Human Services, http://www.hhs.gov/ohrp, or the program administrator in the awarding component. The PHS will make a final determination as to whether the proposed activities are covered by the regulations (i.e., non exempt) or are in an exempt category.
Exempt Research. If all the activities are designated to be exempt from the regulations, insert the exemption number(s) corresponding to one or more of the six exemption categories listed in the NIH Grants Policy Statement or the competing application instructions or the Protection of Human Subject regulations (45 CFR 46.101(b)). The remaining parts of Item 6 are then not applicable.
Non-Exempt Research. If any of the planned activities involving human subjects are not exempt, complete the remaining parts of Item 6. If the applicant organization has a current approved Federal Wide Assurance on file with the OHRP, insert the Assurance number and the most recent date of approval by the Institutional Review Board (IRB) for the proposed activities. This date must not be earlier than one year before the start date for which the Progress Report is submitted. No Progress Report for continuation support should be submitted until the necessary certification of annual IRB review has been obtained.
Policy on research activities involving vertebrate animals can be found in the NIH Grants Policy Statement or the competing application instructions. If activities involving vertebrate animals are not planned at any time during the proposed budget period, check "No." The remaining parts of Item 7 are then not applicable.
Check "Yes” if activities involving vertebrate animals are planned at any time during the budget period, either at the applicant organization or at any other project/performance site or collaborating institution. If the applicant organization has a current approved Animal Welfare Assurance on file with the Office of Laboratory Animal Welfare (OLAW), enter the Assurance number of the applicant organization in Item 7b. In addition, provide certification of current Institutional Animal Care and Use Committee (IACUC) approval of the animal activities. PHS Policy requires that IACUC approval occur within the past three years to be considered current. Progress reports for continuation support should NOT be submitted until the necessary verification of IACUC review has been obtained.
Enter the direct costs from Form Page 2.
Enter the sum of the total direct costs from Item 8a and F&A costs.
Check "No," if no inventions were conceived or reduced to practice during the course of work under this project during the previous budget period.
Check "Yes," if any inventions were conceived or reduced to practice during the course of work under this project during the previous budget period. Check the appropriate box to indicate whether this information has or has not been previously reported to the PHS or to the official responsible for patent matters at the grantee organization.
According to NIH Grants Policy and Federal law, NIH recipient organizations must promptly report all inventions that are either conceived or first actually reduced to practice using NIH grant funds. Invention reporting compliance as specified at 37 CFR 401.14 is described at http://www.iedison.gov. The grantee is encouraged to submit reports electronically using Interagency Edison (http://www.iedison.gov). Inquiries or correspondence should be directed to:
Division of Extramural Inventions and Technology Resources
Office of Policy for Extramural Research Administration, OER, NIH
6705 Rockledge Dr., MSC 7980
Bethesda, MD 20892-7980
(301) 435-1986
Information from these reports is retained by the NIH as confidential and submission does not constitute any public disclosure. Failure to report as described at 37CFR Section 401.14 is a violation of 35 USC 202 and may result in loss of the rights of the recipient organization.
Indicate where work described will be conducted. If work will be conducted at the applicant institution, state “applicant” under Name of Organization; it is not necessary to re-enter the address, DUNS, and Congressional District if it is the same as that provided in block 3 of the Face Page. If more than one site, use the Project/Performance Site Format Page to list all the sites, including Department of Veterans Affairs (VA) facilities and foreign sites. One of the sites indicated must be the applicant organization or be identified as off site in accordance with the applicant organization’s negotiated Facilities and Administrative (F&A) agreement.
If including a NEW Project/Performance Site where either human subjects or vertebrate animals will be involved, indicate a change on the Progress Report Summary, Form Page 5, and address the change in the Summary under D. Plans, item A or B, as appropriate.
If a Project/Performance Site is engaged in research involving human subjects, the applicant organization is responsible for ensuring that the Project/Performance Site operates under an appropriate Federal Wide Assurance for the protection of human subjects and complies with 45 CFR Part 46 and other NIH human subject related policies described in Part II of the competing application instructions and the NIH Grants Policy Statement.
For research involving live vertebrate animals, the applicant organization must ensure that all Project/Performance Sites hold OLAW-approved Assurances. If the applicant organization does not have an animal program or facilities and the animal work will be conducted at an institution with an Assurance, the applicant must obtain an Assurance from OLAW prior to an award.
Name of individual authorized to act for the applicant organization and to assume the obligations imposed by the Federal laws, requirements, and conditions for a grant or grant application, including the applicable Federal regulations. Provide name, title and contact information for the signing official.
Use this space for corrections and changes.
An original signature, in ink, is required. Only an institutional official with formal designated or delegated authority to sign on behalf of the organization may sign the form. The signature must be dated. In signing the Face Page, the AOR of the applicant organization certifies that the applicant organization will comply with all applicable assurances and certifications listed below. The applicant organization is responsible for verifying the accuracy, validity, and conformity with the most current institutional guidelines of all the administrative, fiscal, and scientific information in the progress report, including the Facilities and Administrative cost rate. Deliberate withholding, falsification, or misrepresentation of information could result in administrative actions, such as withdrawal of a progress report, suspension and/or termination of an award, debarment of individuals, as well as possible criminal penalties. The signer further certifies that the applicant organization will be accountable both for the appropriate use of any funds awarded and for the performance of the grant-supported project or activities resulting from this progress report. The grantee institution may be liable for the reimbursement of funds associated with any inappropriate or fraudulent conduct of the project activity.
Each progress report to the PHS requires that the following policies, assurances, and/or certifications be verified by the signature of the Authorized Organization Representative (AOR) on the Face Page of the progress report. These assurances are explained in Part III: Policies, Assurances, Definitions, and Other Information of the competing application instructions. Applicants and grantees must comply with a number of additional public policy requirements. Refer to your institution’s research grant administrative office or the NIH Grants Policy Statement (http://grants.nih.gov/grants/policy/policy.htm) for additional information.
The policies, assurances and certifications listed below may or may not be applicable to your project, program, or type of applicant organization.
Research on Transplantation of Human Fetal Tissue
Research Using Human Embryonic Stem Cells
Women and Minority Inclusion Policy
ClinicalTrials.gov Requirements
Non-Delinquency on Federal Debt
Recombinant DNA Research, including Human Gene Transfer Research
Financial Conflict of Interest (except Phase I SBIR/STTR)
Project Director/Principal Investigator Assurance
Impact of Grant Activities on the Environment and Historic Properties
Institutions Receiving Awards for Training of Graduate Students for Doctoral Degrees
FORM PAGE 2
Itemize the direct costs requested for the next budget period by budget categories. Use the recommended direct cost shown on the spreadsheet included with the Notice of Award issued in the competitive year as the guide for developing the line item annual budget. Use Form Page 3 and continuation pages as necessary to provide required explanation of budget items.
For multi-project grants where individual projects are budgeted separately, additional copies of Form Page 2 should be prepared for each project or core in the program. Number these pages consecutively. Do not use suffixes such as 2a, 2b. On the individual budget pages for each specific project, clearly identify the name of the project leader and the title of the project.
Certain conditions may change the funding requirements for a budget period from those originally recommended. Such proposed funding changes, particularly increases over the recommended level, must be explained and fully justified for PHS awarding component consideration.
Name and Role on Project. Starting with the PD/PI(s), list all employees of the applicant organization who will be involved on the project for at least one person month or more, regardless of whether or not salaries are requested.
Months Devoted to Project.
Enter the number of months devoted to the project. Three columns are provided depending on the type of appointment being reflected, academic, calendar, and/or summer months. Individuals may have consecutive appointments within a calendar year, for example for an academic period and a summer period. In this case, identify each appointment separately using the corresponding column.
If effort does not change throughout the year, use only the calendar months column. If effort varies between academic and summer months, leave the calendar months column blank and use only the academic and summer months columns. In cases where no contractual appointment exists with the applicant organization and salary is requested, enter the number of months devoted to the project period.
If a change in the level of effort for the PD/PI(s) or other Senior/Key Personnel designated on the NoA is proposed from what was approved in the competing year award of this project, a detailed justification must be provided under Section 2.2.3 - Budget Justification.
Salary Requested. Regardless of the number of months being devoted to the project, enter the dollar amounts for each position for which funds are requested. The salary requested may not proportionally exceed any imposed salary limitation. Grantees are encouraged to check the NIH Guide for Grants and Contracts for the salary limitation each year (http://grants.nih.gov/grants/policy/salcap_summary.htm).
Fringe Benefits. Fringe benefits may be requested in accordance with the institutional guidelines for each position, provided the costs are treated consistently by the applicant organization as a direct cost to all sponsors.
Totals. Calculate the totals for each position and enter the subtotals in each column where indicated.
Special Instructions for Individuals with Joint University and Department of Veterans Affairs (V.A.) Appointments
Individuals with joint university and V.A. appointments may request the university’s share of their salary in proportion to the effort devoted to the research project. The individual’s salary with the university determines the base for computing that request. Signature by the institutional official on the application certifies that: (1) the individual is applying as part of a joint appointment specified by a formal Memorandum of Understanding between the university and the V.A.; and (2) there is no possibility of dual compensation for the same work, or of an actual or apparent conflict of interest regarding such work. Additional information may be requested by the awarding components.
Whether or not costs are involved, provide the names and organizational affiliations of all consultants, other than those involved in consortium/contractual arrangements. Include consultant physicians in connection with patient care and persons who serve on external monitoring boards or advisory committees to the project. Briefly describe on Form Page 3 any changes in services to be performed. Include the number of days of anticipated consultation, the expected rate of compensation, travel, per diem, and other related costs.
List separately each item of equipment and justify the purchase on Form Page 3, if not previously approved.
Itemize supplies in separate categories, such as glassware, chemicals, radioisotopes, etc. Categories in amounts less than $1,000 do not have to be itemized. If animals are to be purchased, state the species, strain(s), ages, sex, and the number of animals to be used.
Itemize travel requests and justify on Form Page 3. Provide the purpose and destination of each trip and the number of individuals for whom funds are requested.
Indicate the basis for estimating costs in this category in detail, including the number of patient days, estimated cost per day, and cost per test or treatment. If both inpatient and outpatient costs are requested provide information for each separately, and if multiple sites are to be used, provide the information in detail for each site.
Include information regarding projected patient accrual for the budget period and relate this information to the budget request for patient care costs.
Provide specific information regarding anticipated sources of other support for patient care costs, e.g., third party recovery or pharmaceutical companies. Include potential or expected utilization of General Clinical Research Centers.
Patient care costs do not include travel, lodging, and subsistence or donor/volunteer fees. Request these costs in the Other Expenses category. Request the costs for consultant physician fees in the Consultant Costs category. Patient care costs will be provided to foreign organizations only in exceptional circumstances.
Itemize by category and justify on Form Page 3 the costs of essential alterations and renovations, including repairs, painting, removal or installation of partitions, shielding, or air conditioning. When applicable, indicate the square footage involved, giving the basis for the costs, such as an architect's or contractor's detailed estimate as outlined in the NIH Grants Policy Statement. Line drawings of the proposed alterations should be submitted with the progress report where required by the NIH Grants Policy Statement. Note, costs for any Alterations and Renovations (A&R) were previously unallowable from foreign institutions, international organizations and domestic applications with foreign subawards. However an HHS policy change now allows for minor A&R (<$500,000) on these applications. When requesting minor A&R costs under this policy, provide detailed information on the planned A&R in the budget justification.
Itemize any other expenses by category and unit cost. These might include animal maintenance (unit care costs and number of days), patient travel, donor fees, publication costs, computer charges, rentals and leases, equipment maintenance, service contracts, and tuition remission when budgeted separately from salary/fringe benefits.
Each participating consortium/contractual organization must submit a separate detailed budget (Form Page 2) and budget justification (Form Page 3) for the next budget period. If a new consortium is added, follow the guidelines in the competing application instructions.
List the Facilities and Administrative (F&A) costs, if any, and provide the basis for the rate in the Consortium/Contractual Costs category. Insert the page(s) for each consortium/contractual organization after Form Page 3 and number them consecutively.
The sum of all consortium/contractual costs (direct and F&A) must be entered in the Consortium/Contractual Costs category of the applicant organization's budget.
FORM PAGE 3
Budget Justification. Provide detailed justification for those line items and amounts that represent a significant change from previously recommended levels (e.g., Total rebudgeting greater than 25 percent of the total award amount for this budget period).
If there has been a significant change in the level of effort devoted to the project from what was approved in the competing year award for the PD/PI or other Senior/Key Personnel designated on the NoA, provide a justification of the reduction for those individuals. (A significant change in level of effort is defined in Federal regulations as a 25 percent reduction in time devoted to the project.)
Current Budget Period. In the space provided, or on additional pages, explain any estimated unobligated balance of total costs (including prior year funds carried over) that is greater than 25 percent of the current year's total approved budget. Explain why there is a significant balance and how it will be spent if carried forward into the next budget period. The “total approved budget” equals the current fiscal year award authorization plus any carryover of funds from a prior year. The numerator equals the total amount available for carryover and the denominator equals the current year’s total approved budget.
BIOGRAPHICAL SKETCH FORMAT PAGE
For eSNAP submissions, upload the Biographical Sketches for new senior/key personnel and new Other Significant Contributors at the Upload Science screen, under Files, as "Other File."
Complete a Biographical Sketch for all new senior/key personnel since the previous submission. Each Biographical Sketch is limited to four pages.
Senior/key personnel are defined as, and should be limited to, individuals who contribute in a substantive measurable way to the scientific development or execution of the project, whether or not salaries are requested.
Typically, these individuals have doctoral or other professional degrees, although individuals at the masters or baccalaureate level should be included if their involvement meets the definition of senior/key personnel. Consultants and those with a postdoctoral role should also be included if they meet the same definition. Individuals providing technical services are not considered senior/key personnel.
Complete a Biographical Sketch for all new “Other Significant Contributors.” These individuals are typically those that may contribute to the scientific development or execution of the project, but are not committing any specified measurable effort to the project.
Complete the education/training block at the top of the format page. Begin by listing your baccalaureate or other initial professional education, such as nursing. Include your postdoctoral training and residency training as applicable, and complete sections A, B, C, and D below:
A. Personal statement. Briefly describe why your experience and qualifications make you particularly well-suited for your role (e.g., PD/PI, mentor, participating faculty) in the project that is the subject of the application.
B. Positions and Honors. List in chronological order previous positions, concluding with the present position. List any honors. Include present membership on any Federal Government public advisory committee.
C. NIH encourages applicants to limit the list of selected peer-reviewed publications or manuscripts in press to no more than 15. Do not include manuscripts submitted or in preparation. The individual may choose to include selected publications based on recency, importance to the field, and/or relevance to the proposed research. When citing articles that fall under the Public Access Policy, were authored or co-authored by the applicant and arose from NIH support, provide the NIH Manuscript Submission reference number (e.g., NIHMS97531) or the PubMed Central (PMC) reference number (e.g., PMCID234567) for each article. If the PMCID is not yet available because the Journal submits articles directly to PMC on behalf of their authors, indicate "PMC Journal - In Process." A list of these Journals is posted at: http://publicaccess.nih.gov/submit_process_journals.htm. Citations that are not covered by the Public Access Policy, but are publicly available in a free, online format may include URLs or PMID numbers along with the full reference (note that copies of publicly available publications are not accepted as appendix material.)
D. Research Support. List both selected ongoing and completed research projects for the past three years (Federal or non-Federally-supported). Begin with the projects that are most relevant to the research proposed in the application. Briefly indicate the overall goals of the projects and responsibilities of the key person identified on the Biographical Sketch. Do not include number of person months or direct costs.
For the purposes of the continuation progress report, other support information is only required on active support for all senior/key personnel. Refer to the competing application instructions, definitions, policy, and format pertaining to other support. Do not include other supporting information for individuals designated as other significant contributors unless their involvement has changed so that they now meet the definition of senior/key personnel.
For eSNAPs, the progress report summary is uploaded on the Upload Science screen, under Files, as "Progress Report File."
Non-SNAP awards use FORM PAGE 5.
Well-planned Progress Reports can be of great value by providing records of accomplishments that serve as a basis for continued support of the project. Furthermore, Progress Reports provide information to awarding component staff that is essential in the assessment of changes in scope or research objectives (as defined in the NIH Grants Policy Statement) from those actually funded. They are also an important information source for the awarding component staff in preparing annual reports, in planning programs, and in communicating scientific accomplishments to the public and to Congress.
The Progress Report should be a brief presentation of the accomplishments on the research project during the reporting period, in language understandable to a biomedical scientist who may not be a specialist in the project's research field. The style used in Scientific American articles would be appropriate. Abbreviations and language that may not be known to the broader scientific community should be avoided unless clearly defined.
When submitting Progress Reports for program project grants, center grants, education grants, or other large multicomponent grants, contact the program official of the awarding agency for specific instructions.
The entire Progress Report for regular projects, exclusive of the list of publications and the “Inclusion Enrollment Report,” should not exceed two pages. The report should follow the outline and numbering system shown below. Continuation pages may be used as necessary. Tables and figures that summarize key accomplishments are not counted in the two-page limit.
The aims, as actually funded, may differ in scope from those stated in the original, competing application, because of Scientific Review Group (SRG) and Council recommendations and/or budgetary modifications made by the awarding component. If the aims have not been modified, state this. If they have been modified, give the revised aims and the reason for the modification.
Describe the studies directed toward specific aims during the current budget year and the positive and negative results obtained. If applicable, address any changes to the innovative potential of the project. If technical problems were encountered in carrying out this project, describe how your approach was modified.
Revisions (formerly Supplements): If applicable, include a separate section(s) describing the results obtained by individuals supported on this grant through various revisions. Examples include Research Supplements to Promote Diversity in Health-Related Research, supplements to enhance diversity and Re-entry and/or other similar supplements to support addition of an individual or a discrete project.
Emphasize the significance of the findings to the scientific field and their potential impact on health.
Summarize plans to address the Specific Aims during the next year of support. Include any important modifications to the original plans.
For eSNAPs, complete the Edit Business - Research Subject screen.
For non-SNAP awards, complete item A on Form Page 5.
If the protocols planned for the coming year are different from those proposed in the previous submission, or if a new applicable clinical trial is proposed, include an explanation of how they differ and provide a new or revised Protection of Human Subjects section as described in Part II.3 of the competing application instructions. Include designated headings, as appropriate, for Exempt Human Subjects Research, Non Exempt Human Subjects Research, Clinical Trial, or NIH Defined Phase III Clinical Trial, Data and Safety Monitoring, Inclusion of Women and Minorities, and Inclusion of Children. New protocols or protocol changes will require IRB approval, in accord with the DHHS regulations for protection of human subjects. Provide a protocol only upon request.
If human subject studies planned for the coming year were identified in the Research Plan of the competing application, but were not adequately described because they were planned for a later time within the project period, provide a Protection of the Human Subjects section as instructed in Part II of the competing application instructions.
If studies involving human subjects are planned, and they were not part of the originally proposed research design, provide a Protection of Human Subjects section as instructed in Part II of the competing application instructions, and also provide the following information: whether all of the research is exempt under 45 CFR Part 46, and if so, the exemption number, the Federalwide Assurance number, whether the research is a Clinical Trail and whether the research is an NIH defined Clinical Trial (see definitions in Part III of the competing application instructions).
Public Law 110-85, also known as the Food and Drug Administration Amendments Act (FDAAA) of 2007, mandates registration and results reporting of certain “applicable clinical trials” in ClinicalTrials.gov.
When submitting a non-competing continuation progress report for a project that includes applicable clinical trial(s):
If a new applicable clinical trial is proposed –OR- if the progress report includes an applicable clinical trial that is on-going but not yet required to register under FDAAA (e.g. less than 21 days have passed since enrollment of the first subject), the Human Subjects section of the progress report must include a clear statement, under a heading entitled “ClinicalTrials.gov”, that the project includes an applicable clinical trial which will require registration in ClinicalTrials.gov. Applicable clinical trials must be registered in ClinicalTrials.gov no later than 21 days after the first subject is enrolled.
If the progress report includes an applicable clinical trial that is registered in ClinicalTrials.gov, then the Human Subjects section of the progress report must include, under a heading entitled “ClinicalTrials.gov”, the ClinicalTrials.gov registry number (“NCT” followed by an 8-digit number, e.g. NCT00000418), the Brief Title (protocol title intended for the lay public), and the identity (name, organization) of the responsible party and their contact information (e-mail address-required for internal administrative use only).
In signing the application Face Page or submitting the eSNAP to NIH, the AOR of the grantee organization certifies that if the research is an applicable clinical trial under Public Law 110-85, the applicant organization will be in compliance with the registration and reporting requirements of Public Law 110-85 (Part III, Section 2.1.6 of the competing application instructions). See the NIH Office of Extramural Research ClinicalTrials.gov web site (http://grants.nih.gov/ClinicalTrials_fdaaa) for additional information.
Women and Minority Inclusion in Clinical Research
Reporting Data on Inclusion to NIH:
If you are conducting clinical research as defined in the application instructions, you must report the cumulative enrollment of subjects and their distribution by sex/gender and ethnicity/race on the Inclusion Enrollment Report, unless otherwise notified by your program official. For awards made as a result of New and Competing applications submitted after January 10, 2002, you should be using the Inclusion Enrollment Report in progress reports. For awards made as a result of New and Competing Applications received before January 10, 2002, you may choose to report sex/gender and ethnicity/race composition using EITHER the format in the 4/98 Version of the Inclusion Table (http://grants.nih.gov/grants/funding/phs398/Inclusion498version.doc) or the Inclusion Enrollment Report. If data were collected using two questions (one about ethnicity and one about race) and subjects were given the option of selecting more than one race, then the Inclusion Enrollment Report should be used. If you choose to report information using the Inclusion Enrollment Report, you must continue to use this format for the remaining years of the project. See detailed instructions and frequently asked questions in http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html.
Reporting data on inclusion is not included in the two-page limit. If there is more than one study, provide a separate table for each study. Information about ethnic/racial subpopulations included in the study should be provided as an attachment to the table.
Changes to Targeted/Planned Enrollment: If there are changes from the Targeted/Planned Enrollment originally approved for funding, you should submit a revised Targeted/Planned Enrollment Table and an Inclusion Enrollment Report describing data collected to-date. Explain the changes in a footnote or attachment to the report. The NIH Policy on Reporting Race and Ethnicity Data for Subjects in Clinical Research is described and referenced in Part II, Section 5.8 of the competing application instructions.
NIH-defined Phase III Clinical Trial: If you are conducting an NIH-defined Phase III Clinical Trial as defined in Part III of the competing application instructions, you must report on the cumulative enrollment (as described above) and indicate if data analysis has begun for the trial. If analysis has begun, report on progress made in conducting valid analyses for sex/gender and ethnic/racial differences.
Foreign Populations: If you are conducting clinical research outside of the US, you should design culturally sensitive and appropriate data collection instruments that allow participants to self-identify their ethnic and racial affiliation. These items, however, should be designed in a way that allows the information to be aggregated into the OMB minimally required ethnic and racial categories and complete the Inclusion Enrollment report. When completing the Inclusion Enrollment report, you should add an asterisk and footnote the report to indicate that data is from foreign participants. If your study includes both domestic and foreign participants, we suggest submitting two separate reports – one for domestic data and one for foreign data, with an asterisk and footnote explaining the foreign data.
The enrollment data by race may be lower than the Targeted/Planned enrollment by race because some individuals may designate that they belong to more than one race and will report under "More Than One Race" category. In this case, you may discuss these discrepancies in an attachment to the Inclusion Enrollment report.
Standards for Collecting Data from Study Participants:
When you are planning collection of data on ethnicity and race, as well as sex/gender, you should use the categories listed below to obtain the data from individuals. The collection of greater detail is encouraged, e.g., on ethnic/racial subpopulations; however, any collection that uses more detail shall be organized in such a way that the additional categories can be aggregated into these minimum categories for reporting data on ethnicity and race. Using self-report or self-identification to collect this information, you should use two separate questions, with ethnicity information collected first followed by the option to select more than one racial designation. When reporting these data in the aggregate, you should report:
(a) the number of subjects in each ethnic category;
(b) the number of subjects who selected only one category for each of the five racial categories;
(c) the total number of subjects who selected multiple racial categories reported as the “number selecting more than one race”; and,
(d) the number of subjects in each racial category who are Hispanic or Latino.
NIH is required to use these definitions to allow comparisons to other federal databases, especially the census and national health databases. Federal agencies shall not present data on detailed categories if doing so would compromise data quality or confidentiality standards (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html).
The Inclusion Enrollment Report format is not designed for use as a data collection instrument. You should collect the data using instruments prepared for the study and use the information from the study database to fill out the enrollment report. Study participants who select two or more racial categories should be reported in the aggregate in the "More Than One Race" category.
The Office of Management and Budget (OMB) Directive No. 15 defines minimum standards for maintaining, collecting and presenting data on ethnicity and race for all Federal (including NIH) reporting purposes. The categories in this classification are social-political constructs and should not be interpreted as being anthropological in nature. The standards were revised in 1997 and now include two ethnic categories: Hispanic or Latino, and Not Hispanic or Latino. There are five racial categories: American Indian or Alaska Native, Asian, Black or African American, Native Hawaiian or Other Pacific Islander, and White. Reports of data on ethnicity and race should use these categories. The following definitions apply for the ethnic and racial categories.
Ethnic Categories:
Hispanic or Latino: A person of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. The term, “Spanish origin,” can be used in addition to “Hispanic or Latino”.
Not Hispanic or Latino
Racial Categories:
American Indian or Alaska Native: A person having origins in any of the original peoples of North, Central, or South America and maintains tribal affiliation or community.
Asian: A person having origins in any if the original peoples of the Far East, Southern Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam.
Black or African American: A person having origins in any of the black racial groups of Africa. Terms such as “Haitian” or “Negro” can be used in addition to “Black or African American.”
Native Hawaiian or Other Pacific Islander: A person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.
White: A person having origins in any of the original peoples of Europe, North Africa, or the Middle East.
Ethnic/racial subpopulations. In addition to the OMB ethnic and racial categories, NIH uses the following definition for ethnic/racial subpopulations:
Subpopulations. Each ethnic/racial group contains subpopulations that are delimited by geographic origins, national origins, and/or cultural differences. It is recognized that there are different ways of defining and reporting racial and ethnic subpopulation data. The subpopulation to which an individual is assigned depends on self-reporting of specific origins and/or cultural heritage. Attention to subpopulations also applies to individuals who self identify with more than one ethnicity or race. These ethnic/racial combinations may have biomedical, behavioral, and/or social-cultural implications related to the scientific question under study. (http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm).
Human Subjects Education Requirement
If there are any new senior/key personnel or other significant contributors involved in the design or conduct of research involving human subjects, provide certification that they have completed an educational program in the protection of human subjects. This requirement may not apply to other awarding agencies. Non-NIH grantees should contact their awarding agency for guidance (refer to table in Section 1.1).
[For eSNAPs, provide this certification on the Edit Business - Research Subject screen in the Human Subjects Education text field box. For non-SNAP awards, provide this certification in the Progress Report Summary.]
For eSNAPs, complete the relevant question on the Edit Business - Research Subject screen.
For non-SNAP awards, complete item B on Form Page 5.
If vertebrate animals were not involved in the last application but are now to be included, or if significant changes regarding the use of animals are now proposed, provide a description of the intended involvement of animals in accord with the PHS Policy on Humane Care and Use of Laboratory Animals. Examples of changes considered to be significant include, but are not limited to, changing animal species, changing from noninvasive to invasive procedures, new project/performance site(s) where animals will be used, etc. If studies involving live vertebrate animals are planned, and they were not part of the originally proposed research design, you must comply with the requirements of the Research Plan, Item 5.5.10, “Vertebrate Animals,” described in the competing application instructions, and provide the required information. Before activities with live vertebrate animals begin, the applicant must provide a valid Animal Welfare Assurance number and certification of current IACUC approval.
Select Agent Research
For eSNAPs, complete the relevant question on the Edit Business – SNAP and Other Progress Report Questions and Checklist screen.
For non-SNAP awards, complete item C on Form Page 5. If there are any changes involving use of Select Agents, include an explanation of how research plans differ and provide a new or revised Section 5.5 Select Agent Research of the Research Plan following the competing application instructions, reflecting the changes.
If Select Agent Research planned for the coming year was described in the Research Plan of the competing application, but had not been approved by regulatory authorities, provide the Select Agent Research information requested in the competing application instructions.
If studies involving Select Agents are planned, but were not part of the originally proposed research design, provide Section 5.5 Select Agent Research of the Research Plan following the competing application instructions.
Multiple PD/PI Leadership Plan
This section is only applicable if Multiple PD/PIs are part of the NIH approved project.
For eSNAPs, complete the relevant question on the Edit Business – SNAP and Other Progress Report Questions and Checklist screen.
For non-SNAP awards complete item D on Form Page 5.
If there has been any change in the governance and/or organizational structure of the Multiple PD/PI Leadership Plan, provide a description, including communication plans and procedures for resolving conflicts, any changes to the administrative, technical, and scientific responsibilities for the PD/PIs.
If the progress report submission includes a change in the contact PD/PI, address this change and the impact, if any, the change has on the administrative, technical, and scientific responsibilities for the PD/PIs.
Human Embryonic Stem Cell Line(s) Used
For eSNAPs, complete the relevant question on the Edit Business – SNAP and Other Progress Report Questions and Checklist screen.
For non-SNAP awards, complete item E on Form Page 5.
If the research involving hESCs planned for the coming year is different from that proposed in the previous submission, including use of a different cell line, include an explanation of how research plans differ, and if different cell lines are to be used, provide the cell line number(s). Only cell lines listed on the NIH hESC Registry as approved for use in NIH funded research may be used.
For eSNAPs, in the lower half of the Upload Science screen, select any listed publication in order to associate a publication with the progress report.
For non-SNAP awards, citations must be provided in the Progress Report Summary (Form page 5).
Report publications resulting directly from this grant that you have not previously reported, including manuscripts submitted or accepted for publication. Provide the complete citation (author(s), title, journal or book, volume, page number, year). If available electronically provide a url or PMCID number. If not available electronically you may provide one copy with the progress report. State if there have been no publications.
For each publication that falls under the Public Access Policy, provide the NIH Manuscript Submission reference number (e.g., NIHMS97531) or the PubMed Central (PMC) reference number (e.g., PMCID234567), at the end of the citation. If the PMCID is not yet available because the Journal submits articles directly to PMC on behalf of their authors, indicate "PMC Journal - In Process." A list of these Journals is posted at: http://publicaccess.nih.gov/submit_process_journals.htm.
A citation management tool “My Bibliography” is now integrated with eRA Commons and is to be used to manage publication citations in the eSNAP Upload Science screen. “My Bibliography” includes an export function, which allows the tool to be used for managing citations in biosketches and in progress reports for non-SNAP awards. My Bibliography will display the correct text format, and if available, include the appropriate reference number (PMID, PMCID, or NIHMSID). For addition information about “My Bibliography”, see NIH Guide Notice NOT-OD-10-103.
For additional information on compliance with the Public Access Policy see NIH Guide Notice NOT-OD-08-119 and NOT-OD-09-136.
If the research supported by this grant resulted in data, research materials (such as cell lines, DNA probes, animal models), protocols, software, or other information available to be shared with other investigators, describe the resource and how it may be accessed.
If the initial research plan included a formal plan for sharing final research data, describe progress in implementing that plan. A final statement on data sharing should be included in the final progress report or earlier, if the plan is implemented prior to closeout.
If the initial research plan included specifics for sharing model organisms, include information on the progress of that plan as well as information on the number of requests received and fulfilled.
If the initial research plan includes Genome Wide Association Studies and a plan to share data with the NIH centralized data repository, describe progress in implementing that plan. A final statement on submitting data to the repository should be included in the final progress report or earlier, if the plan is implemented prior to closeout (see NOTICE OD-08-023 and NOTICE OD-07-088).
FORM PAGE 6
See the competing application instructions and the NIH Grants Policy Statement for information on program income. If no program income is anticipated during the period(s) for which grant support is requested, no other action is necessary.
If program income is anticipated, use the format provided. If the progress report is funded, the Notice of Award will provide specific instructions regarding the use of such income.
Each progress report to the PHS requires that the policies, assurances and certifications listed in Section 2.2.1 be verified by the signature of the Official Signing for Applicant Organization on the Face Page of the progress report (see Item 13). If unable to certify compliance where applicable, provide an explanation and place it after the Progress Report (Form Page 5).
Follow the instructions on the Checklist.
For eSNAPs, complete the All Personnel Report from the Edit Business tab.
For non-SNAP awards, complete form page 7. For additional information about the All Personnel Report see the FAQs at: http://grants.nih.gov/grants/funding/all_personnel_report_faq.htm.
Always list the PD/PI(s). In addition, list all other personnel (salaried and unsalaried) for the current budget period at the applicant organization or elsewhere, who participated in the project during the current budget period for at least one person month or more, regardless of the source of compensation. A person month equals approximately 160 hours or 8.3% of annualized effort. Include the Commons ID (when applicable) names of individuals, all degrees, the last four digits of the Social Security number, role on project, date of birth (MM/YY), and number of person months devoted to the project (indicate academic, calendar, and/or summer).
When requesting the last four digits of the Social Security numbers from personnel, explain that provision of the Social Security number is voluntary, and the information will be used only for program management purposes. The Commons ID is required for all PD/PIs and all individuals with a postdoctoral role; it is optional for all other personnel.
Use the following categories for describing Role on Project:
PD/PI
Co-Investigator
Faculty Collaborator
Staff scientist (doctoral level)
Postdoctoral Scholar, Fellow, or Other Postdoctoral Position
Graduate Research Assistant
Undergraduate Research Assistant
Research Assistant/Coordinator
Technician
Consultant
Other (please specify)
If personnel are supported by a Reentry or Diversity Supplement or American Recovery and Reinvestment Act (ARRA) funding, please indicate such after the Role on Project, using the following abbreviations:
RS - Reentry Supplement
DS - Diversity Supplement
AF - General ARRA Supplement
ASE - ARRA Summer Experience funding.
Individuals designated as “Other Significant Contributors,” (e.g., those that may contribute to the scientific development or execution of the project, but are not committing any specified measurable effort to the project), should not be included in this report unless their involvement has changed so that they are now participating in the project during the current budget period for at least one person month or more.
Grantees should not report personnel if they have submitted a 2271 Appointment form for those individuals (e.g., participants on R25 or R90 awards).
For non-SNAP awards, this is the last page of the hard copy progress report. Number all pages consecutively.
A final progress report is required for any grant that is terminated and any award that will not be extended through award of a new competitive segment. The final progress report should include a summary of progress toward the achievement of the originally stated aims, a list of significant results (positive or negative), and a list of publications. When citing articles that fall under the Public Access Policy, provide the NIH Manuscript Submission reference number (e.g., NIHMS97531) or the PubMed Central (PMC) reference number (e.g., PMCID234567) for each article. If the PMCID is not yet available because the Journal submits articles directly to PMC on behalf of their authors, indicate "PMC Journal - In Process." A list of these Journals is posted at: http://publicaccess.nih.gov/submit_process_journals.htm.
The final progress report also should address the following:
Report on the inclusion of gender and minority study subjects (using the gender and minority inclusion table as provided in the PHS 2590)
Where appropriate, indicate whether children were involved in the study or how the study was relevant for conditions affecting children (see the Grants Policy Statement and competing application instructions).
Describe any data, research materials (such as cell lines, DNA probes, animal models, etc.), protocols, software, or other information resulting from the research that is available to be shared with other investigators and how it may be accessed.
If there are any other specific requirements set forth in the terms and conditions of the award they must be addressed in the final progress report as well. Additional information on submitting final progress reports to AHRQ, CDC, FDA and IHS can be obtained from their websites.
ELECTRONIC SUBMISSION OF FINAL PROGRESS REPORT
Electronic submission is strongly encouraged for all NIH grantees. Grantee institutions registered in the eRA Commons should submit the final progress report electronically through the eRA Commons available at https://commons.era.nih.gov/commons/. Additional information on electronic submission of closeout documents is available at the NIH eRA Commons homepage or by contacting the eRA help desk at: http://ithelpdesk.nih.gov/eRA/ or Toll-free (866) 504-9552, Phone 301-402-7469, TTY 301-451-5939.
If closeout documents are not submitted electronically through the eRA Commons, the original final progress report should be submitted to the centralized mailing address in Section 1.
Additional information on submitting closeout documents to AHRQ, CDC, FDA and IHS can be obtained from their website.
Federal Agencies have a continuing commitment to monitor the operation of its review and award processes to detect, and deal appropriately with, any instances of real or apparent inequities. In addition, section 403 of the 2007 NIH Reform Act requires NIH to report to Congress specifically on postdoctoral individuals supported on research grants; and section 489 of the PHS Act requires NIH perform a continuing assessment of research personnel needs. Personal demographic data on PD/PIs and those with a postdoctoral role is vital to comply with these requirements.
NIH collects personal data through the eRA Commons Person Profile. The data is provided one-time by the individual through a secure, electronic system, is confidential, and is maintained under the Privacy Act record system 09-25-0036, “Grants: IMPAC (Grant/Contract Information).” When completing the data entry in the Commons Personal Profile, the individual is responsible for providing true, accurate, and complete data. All analyses conducted on date of birth, citizenship, gender, race, ethnicity, disability, and/or disadvantaged background data will report aggregate statistical findings only and will not identify individuals. Declining to provide information does not affect consideration of an application; however, for some programs (e.g., Ruth L. Kirschstein National Research Service Awards and Research Career Development Awards) citizenship data is required to determine eligibility.
The PHS also requests the last four digits of the Social Security Number (SSN) for accurate identification of individuals and for management of PHS grant programs. Please be aware that no individual will be denied any right, benefit, or privilege provided by law because of refusal to disclose this portion of the SSN. The PHS requests the last four digits of the SSN under Sections 301(a) and 487 of the PHS Act as amended (42 U.S.C. 241a and U.S.C. 288).
The Privacy Act of 1974 (5 USC 552a) is a records management statute and regulates the collection, maintenance, use, and dissemination of personal information by Federal agencies. In accordance with the Act, the PHS is required to provide the following notification to each individual from whom information is requested.
The PHS maintains progress reports and grant records pursuant to its statutory authority for awarding grants. The purpose of the information collection is to aid in the review, award, and administration of PHS programs. Provision of information is voluntary; however, a lack of sufficient information may hinder the PHS' ability to review progress reports, monitor grantee performance, or perform overall management of grant programs.
The Privacy Act authorizes discretionary disclosure of this information within the Department of Health and Human Services (DHHS) and outside the Agency to the public, as required by the Freedom of Information Act and the associated DHHS regulations (45 CFR 5), including: Congress acting within its legislative authority; the National Archives; the General Accounting Office; the Bureau of Census; law enforcement agencies; and pursuant to a court order.
Information may also be disclosed outside the Department for the following purposes:
1. To a Congressional office at the request of the record subject;
2. To the Department of Justice as required for litigation;
3. To the cognizant audit agency for auditing;
4. To qualified experts not within the definition of Department employees, as prescribed in Department Regulations (45 CFR 5b.2), for opinions as part of the progress report review/award process;
5. For an authorized research purpose under specified conditions;
6. To contractors for the purpose of processing, maintaining, and refining records in the system. Contractors will be required to maintain Privacy Act safeguards with respect to such records;
7. To a Federal agency, in response to its request, in connection with the letting of a contract or the issuance of a license, grant, or other benefit by the requesting agency, to the extent that the records are relevant and necessary to the requesting agency's decision on the matter; and
8. To the applicant organization in connection with the review of a progress report or performance or administration under the terms and conditions of the award, or in connection with problems that might arise in performance or administration if an award is made.
Under the provisions of the Privacy Act, program directors/principal investigators may request copies of records pertaining to their grant progress reports from the PHS component responsible for funding decisions. PD/PIs are given the opportunity under established procedures to request that the records be amended if they believe the records are inaccurate, untimely, incomplete, or irrelevant. If the PHS concurs, the records will be amended.
The PHS makes information about awarded grants available to the public, including the title of the project, the grantee institution, PD/PI, abstract, and amount of the award.
The Freedom of Information Act and implementing DHHS regulations (45 CFR Part 5) require the release of certain information about grants upon request, regardless of the intended use of the information. Generally available for release, upon request are: all funded grant applications and progress reports including their derivative funded revision application progress reports; pending and funded continuation progress reports; progress reports of grantees; and final reports of any review or evaluation of grantee performance conducted or caused to be conducted by the DHHS. Generally not available for release to the public are: competing grant progress reports (initial, competing continuation, and supplemental) for which awards have not been made; evaluative portions of site visit reports; and summary statements of findings and recommendations of review groups. Trade secrets and commercial, financial, or otherwise proprietary information may be withheld from disclosure. Information, which, if disclosed, would be a clearly unwarranted invasion of personal privacy, may also be withheld from disclosure. Although the grantee institution and the principal investigator will be consulted about any such release, the PHS will make the final determination. If a requested document contains both disclosable and nondisclosable information, the nondisclosable information will be redacted and the balance of the document will be released.
By regulation (45 CFR 74.36), grantees that are institutions of higher education, hospitals, or non-profit organizations are required to provide, in response to a FOIA request, the research data first produced under the award. Research data” is defined as the recorded factual material commonly accepted in the scientific community as necessary to validate research findings. It does not include preliminary analyses; drafts of scientific papers; plans for future research; peer reviews; communications with colleagues; physical objects (e.g., laboratory samples, audio or video tapes); trade secrets; commercial information; materials necessary to be held confidential by a researcher until publication in a peer-reviewed journal; information that is protected under the law (e.g. intellectual property); personnel and medical files and similar files, the disclosure of which would constitute an unwarranted invasion of personal privacy; or information that could be used to identify a particular person in a research study.
These requirements do not apply to commercial organizations or to research data produced by State or local governments. However, if a state or local governmental grantee contracts with an educational institution, hospital or non-profit organization, and the contract results in covered research data, those data are subject to these disclosure requirements.
The instructions in Sections 1-3 are to be used with these additional instructions to request continuation of all career development awards (K series). For those applying under the Streamlined Noncompeting Award Process (SNAP), use the SNAP instructions in Section 2.1, Streamlined Noncompeting Award Process (SNAP) and the instructions below for Items 5.1.2, 5.1.4, 5.1.5 and 5.1.7. Awardees should consult the applicable Funding Opportunity Announcement and the awarding Federal agency for any supplemental Instructions.
FORM PAGE 2
Base the awardee's salary and fringe benefits request on a full-time, 12-month appointment following the guidelines in the appropriate career award instructions. Support for other personnel and amounts in other budget categories may be requested in accordance with applicable CDA guidelines.
BIOGRAPHICAL SKETCH FORMAT PAGE
Complete for new senior/key personnel and other significant contributors if allowable under guidelines for the appropriate K award.
Provide Other Support information for the career award recipient, sponsor/mentor(s), co-sponsors and senior/key personnel only if changed from the previous submission. For the purposes of the noncompeting continuation progress report, other support information is only required on active support for these individuals. There is no form page for Other Support. Provide the information in the format shown in the example on the 2590 Forms Page (http://grants.nih.gov/grants/funding/2590/2590.htm).
Follow the instructions for regular research projects found in Section 2.2.6, Progress Report Summary, using the outline for items A-F. Complete information on human subjects and/or vertebrate animals only if the awardee has participated in research involving human subjects or vertebrate animals that has not been reported within the progress report of any other PHS-supported project. In addition, complete Items G-J below. The awardee completes Items G, H, and I; the mentor or supervisor who has the responsibility for the awardee’s research career development completes Item J. The Progress Report Summary, including Items G-J, should not exceed four pages.
Briefly describe the awardee’s involvement in activities during the past year designed to increase research skills. Include formal course work, progress toward a research-related degree (if applicable), informal instruction in specific research skills, scientific seminars and meetings, training in the responsible conduct of research, visits to other laboratories, etc. Describe instruction, or participation as a course director, etc. in the case of senior career awardees, in both formal and informal instruction in responsible conduct of research in the past budget period, if applicable. If instruction, or participation as a course director, etc., occurred in a prior budget period, the PI should note the date of occurrence. Any activities undertaken to individualize instruction appropriate to the career stage of the PI should be discussed. (Additional detailed guidance on this requirement is found in the competing application instructions at Part III, Section 1.16.) Indicate any changes in senior/key personnel and other significant contributors (department head, sponsor, and collaborators) during the past year.
Briefly describe the awardee's involvement in activities other than research and research training during the past year. Describe activities such as teaching, clinical care, professional consultation, service on advisory groups, and administrative activities. Indicate percent of time spent in each of these activities and the relationship to the awardee's research career development.
For awards that include a requirement to mentor others (e.g., K05 and K24), indicate the percent of time devoted to mentoring activities, individuals mentored during the reporting period, the frequency and kinds of mentoring, financial and other support provided to mentees, and the productivity of the mentoring relationship.
Provide information on similar activities (to those provided in Item G and Item H for the past year) planned for the next year. Awardees should provide a timeline for these activities, including plans to apply for subsequent grant support. Recipients of transition awards (e.g., K22, K99) should report on their progress in identifying an independent research position. Additionally, awardees charged with mentoring others (e.g., K05, K24) should provide information describing planned mentoring activities and proposed mentees (e.g., backgrounds, interests, professional levels, etc.) sufficient to evaluate the quality of the mentoring.
Prepare a statement assessing the awardee's progress and performance during the past year, both in research and in terms of development into an independent investigator in the area of the award. Include information on the availability of support for the candidate’s research project during the next budget segment. For applicable career transition awards (e.g., K22, K99), describe the awardee’s efforts to transition into a permanent research position and the sponsor’s contributions to that process.
Provide the number of human subjects only if the career awardee has participated in research involving human subjects that has not been reported within the Progress Report of any other PHS-supported project.
FORM PAGE 6
Facilities and Administrative (Indirect) costs on career awards will be awarded at 8 percent of modified direct costs.
For eSNAPs, complete the All Personnel Report from the Edit Business tab for the awardee and mentor(s), if applicable, and any other individuals with one person month effort or more. For non-SNAP awards, provide this information on form page 7.
For non-SNAP awards, this is the last page of the progress report; number all pages consecutively.
Progress reports to continue support of a PHS Institutional Ruth L. Kirschstein National Research Service Award (Kirschstein-NRSA) or non-NRSA research training grant must be submitted on PHS 2590 forms. The due date for these progress reports is determined by the awarding component. Grantees access a website to determine when progress reports are due. The Office of Policy for Extramural Research Administration, OER, National Institutes of Health (NIH) hosts the website located at: http://era.nih.gov/userreports/pr_due.cfm. Grantees are responsible for periodically checking the list, which is updated on/around the 30th of each month. In addition to this website, e-mail reminders are sent to the PI.
For grantee institutions and PIs registered in the eRA Commons, the progress report due information is available in the Commons Status system. Commons-registered institutions and PIs also have access to pre-populated face pages for the PHS 2590 Progress Report via Status. For more information on the Commons, see: https://commons.era.nih.gov/commons/index.jsp.
This section contains additional instructions, a substitute budget page, Trainee Diversity Report page and Trainee Report Tables 12A and 12B to be used to request continuation (noncompeting) support under the PHS institutional Kirschstein-NRSA as well as non-NRSA programs. Follow both sets of instructions in preparing your progress report.
Follow instructions (Items 1-5).
In many instances, trainees supported by institutional training grants will be participating in research projects for which the Institutional Review Board (IRB) review of human subjects is complete or an exemption is designated. This review or exemption designation is sufficient, providing the research would not be substantially modified by participation of a trainee. The appropriate grants must be identified along with their IRB review dates or exemption designation. If space is insufficient in Item 6a, indicate "Next Page" and provide the information on a plain sheet of paper after the Face Page.
If the applicant organization has an approved Federal Wide Assurance or Multiple Project Assurance on file with the Office for Human Research Protections (OHRP) but, at the time of progress report, plans for the involvement of human subjects are so indefinite that IRB review and approval are not feasible, check "Yes" and insert "Indefinite" at Item 6a. If an award is made, human subjects may not be involved until a certification of the date of IRB approval, or a designation of exemption, has been submitted to the PHS awarding component.
In many instances, trainees supported by institutional training grants will be participating in research projects for which the Institutional Animal Care and Use Committee (IACUC) review is complete. This review is sufficient, providing the research would not be substantially modified by participation of a trainee. The appropriate grants must be identified along with the current IACUC review dates. IACUC approval must have occurred within the past three years to be considered current. If space is insufficient in Item 7, indicate "Next Page" and provide the information on a plain sheet of paper after the Face Page.
Check "Yes" and insert "Indefinite" at Item 7 if the applicant organization has an approved Animal Welfare Assurance on file with Office of Laboratory Animal Welfare (OLAW), but at the time of progress report, plans for the involvement of vertebrate animals are so indefinite that IACUC review and approval are not feasible. If an award is made, vertebrate animals may not be involved until a verification of the date of IACUC approval has been submitted to the PHS awarding component.
The institution must ensure that trainees are enrolled in the institution’s animal welfare training and occupational health and safety programs for personnel who have contact with animals, as appropriate. It is also the institution’s responsibility to ensure that trainees are properly supervised when working with live vertebrate animals.
Not applicable.
For Kirschstein-NRSA institutional training grants, the signature of the official signing on behalf of the institution also assures that postdoctoral trainees have been informed of payback requirements associated with the Kirschstein-NRSA program.
FORM PAGE 2
The policy concerning tuition, fees and health insurance for Kirschstein-NRSA training grants was finalized March 24, 2010; see NOT-OD-10-073 for details. Two sets of instructions are provided in this section to provide separate guidance for awards issued under the old and new tuition policies. For non-NRSA training grant programs, refer to the FOA for instructions about budget reporting.
2a. Sunsetting Policy
These instructions apply to non-competing continuation progress reports where the last competing award was issued prior to fiscal year 2006 (October 1, 2005 through September 30, 2006). These grants have health insurance awarded as part of the tuition and fees budget category and will continue this business practice until the next competitive renewal application.
Use the Kirschstein-NRSA substitute budget page, and follow the instructions below, to request direct costs for the next budget period. Any additional information should be provided on Form Page 3.
Stipends
Enter the number of trainees and stipend level for each trainee. Identify, by name, all trainees to be continued and new trainees to whom a commitment has been made for the next budget period.
Tuition, Fees, and Health Insurance
Itemize tuition, individual fees, and either self-only or family health insurance. If tuition varies (e.g., in-state, out-of-state, student status, or dual-degree program), identify these separately. Tuition at the postdoctoral level is limited to that required for specified courses. Tuition, fees, and health insurance may be requested only to the extent that the same resident or nonresident tuition, fees, and health insurance are charged to typical non-Federally-supported students.
Trainee Travel
State the purpose of any travel; give the number of trips involved, the destinations, and the number of individuals for whom funds are requested. Justify foreign travel in detail, describing its importance to the training experience.
Training-Related Expenses
Funds to defray other costs of training, such as staff salaries, consultant costs, equipment, research supplies, staff travel, etc., are requested as a lump sum based on the predetermined amount per predoctoral and postdoctoral trainee. Enter the total dollar figure only. No further itemization or explanation is required.
2b. Transitioning Pilot Policy
These instructions apply to non-competing continuation progress reports where the last competing award was issued in fiscal year 2006 and beyond. (Note the Federal fiscal year is from October through September.) These grants have health insurance awarded as part of the training related expenses budget category.
Use the Kirschstein-NRSA substitute budget page, and follow the instructions below, to request direct costs for the next budget period. Any additional information should be provided on Form Page 3.
Stipends
Enter the number of trainees and stipend amount for each trainee. Identify, by name, all trainees to be continued and new trainees to whom a commitment has been made for the next budget period.
Tuition and Fees (excluding Health Insurance)
Institutions are referred to the new policy for funding of tuition, fees, and health insurance, NOT-OD-06-093, dated August 18, 2006.
In this category, itemize tuition and individual fees only. If tuition varies (e.g., in-state, out-of-state, student status, or dual-degree program), identify these separately. Tuition at the postdoctoral level is limited to that required for specified courses. Tuition and fees may be requested only to the extent that the same resident or nonresident tuition and fees are charged to regular non-Federally-supported students and postdoctoral fellows.
Trainee Travel
State the purpose of any travel; give the number of trips involved, the destinations, and the number of individuals for whom funds are requested. Justify foreign travel in detail, describing its importance to the training experience.
Training Related Expenses (including Health Insurance)
Funds to defray other costs of training, such as health insurance (self-only or family, as applicable), staff salaries, consultant costs, equipment, research supplies, staff travel, etc., are requested as a lump sum based on the predetermined amount per predoctoral and postdoctoral trainee. Enter the total dollar figure only.
While health insurance is included as part of this category and will be awarded as a lump sum based on the new policy, the actual costs of applicable self-only or family health insurance for potential trainees should be separately identified in the budget.
FORM PAGE 3
Indicate whether all stipends awarded for the current budget period will be used and explain any estimated unexpended balance. Explain any rebudgeting from trainee positions (stipends) into tuition and fees that has occurred in the current budget period, including the number of trainee positions (predoctoral and postdoctoral) and the estimated dollar figure that was rebudgeted during the budget period being reported. In addition, if rebudgeting is planned in the upcoming budget period, include similar information on those plans as well.
BIOGRAPHICAL SKETCH FORMAT PAGE
Provide biographical sketches only for newly added training faculty.
Not applicable.
FORM PAGE 5
Use the following instructions to prepare a progress report, which provides a presentation of the accomplishments and changes in the training program during the reporting period, following the outline below: For grantees submitting the first progress report since award of a grant renewal, the reporting period should include all months since submission of the renewal application.
1. Provide a description of the training objectives and goals for the reporting period. Highlight progress in implementation and developments or changes that have occurred. Note any difficulties encountered by the program. Describe changes in the program for the next budget period, including changes in training faculty and significant changes in available space and/or facilities. Include, as appropriate, the role of external advisory committees, significant new training content, procedures or experiences, and indicate how these aid in strengthening and realizing the objectives and goals of the program.
2. Describe the nature of the instruction in the responsible conduct of science and the extent of trainee and faculty participation. Include a description of any enhancements and/or modifications to the five instructional components from the plan described in the awarded application. Specific training faculty members who were contributors to formal instruction in responsible conduct of research during the last budget period must be named. (Additional detailed guidance on this requirement is found in the competing application instructions at Part III, Section 1.16.)
3. Describe activities related to recruitment and retention of trainees from diverse groups.
4. If trainees took part in research involving select agents with faculty participating in the training program, address the requirements of Select Agent Research described in Section 2.2.6.D.
Provide data on the Inclusion Enrollment Report only if the trainees have participated in research involving human subjects that has not been reported within the progress report of another PHS-supported project.
1. Update the data on trainees supported by the training grant in
Table
12A and/or 12B,
as applicable, to reflect new appointments and other changes that
have occurred over the reporting period. For trainees who have left
the program, and those trainees who have completed their training
during this reporting period, indicate the degree earned and the
nature of their current positions. Include the name of the
institution, type, research involvement, and any other relevant
information. Do not include data that is more than 10 years
old.
Grantees that have never completed Table 12A and/or
Table 12B should provide the applicable Table(s) with complete data
on all trainees supported by the grant. Instructions for completing
Tables 12A and 12B may be found in the PHS 2590 Sample Data Tables
12A and 12B (see:
http://grants.nih.gov/grants/funding/2590/2590.htm#2590Sampledatatables).
Thereafter, updated tables will be required with each progress
report through the end of the project period.
Grantees
with NIH institutional training grant awards with specified activity
codes are required to provide program statistics in Table 12A,
indicating the percentage of students admitted for study who
successfully attain a doctoral degree, and the average time between
the beginning of graduate study and the receipt of a doctoral degree
(not including any leaves of absence). NIH activity codes affected
by this requirement are: D43, TU2, T15, T32, T37, T90, U2R,
U90, and U54/TL1.
2. Use the Trainee Diversity Report format page to report on the
diversity of the trainees supported by this grant during the
reporting period. Enter the Grant Number including support year
reported, the Training Grant Title, and Total Number of Trainees
Appointed during the reporting period. In Part A of the report,
indicate for all trainees the
numbers that fall into each ethnic and racial category. The number
of multi-racial trainees will be entered into the row “more
than one race.” Normally, the unknown or not-reported
categories will not be needed.
In Part B of the report,
indicate for “Hispanic or Latino” trainees the numbers
that fall into each racial category. In Part C of the report,
indicate the number of Trainees with Disabilities or are from
Disadvantaged Backgrounds. Definitions of the indicated racial and
ethnic categories are described in the competing
application instructions.
3. Include a paragraph that describes the research project and course work of each trainee supported during the reporting period, as well as any conference presentations, honors, fellowships, etc.
4. List the titles and complete references (author(s), journal or
book, year, page number) of all trainee publications not
previously reported, including those by former trainees
still in research training. This includes manuscripts submitted or
accepted for publication. Citations that are not covered by the
Public Access Policy but are publicly available in a free, on-line
format may include URLs or the PubMed Central numbers (PMCID) along
with the full reference.
Peer-reviewed trainee
publications that arise from support of the training grant must be
submitted to PubMed Central in accord with the Public Access Policy,
and the PubMed Central reference number (PMCID) or NIH Manuscript
Submission reference number (NIHMS ID) provided. If the publication
was already submitted because it also arose as the result of other
NIH support, simply provide the PMCID or NIHMS ID. If the PMCID is
not yet available because the Journal submits articles directly to
PMC on behalf of their authors, indicate "PMC Journal - In
Process." A list of these Journals is posted at:
http://publicaccess.nih.gov/submit_process_journals.htm.
FORM PAGE 6
Facilities and Administrative (F&A) costs under institutional Kirschstein-NRSAs, other than those issued to State or local government agencies, will be awarded at 8 percent of total modified direct costs (excluding the tuition/fees category and sub-grants and contracts in excess of $25,000). Equipment is also excluded on those training grants where Training Related Expenses are not calculated on a lump-sum basis, such as the MARC or COR Honors Undergraduate Research Training Grants. The treatment of health insurance will vary according to the policies under which a Kirschstein-NRSA award was made (for details, see Item 2). State and local government agencies will receive awards at their full Facilities and Administrative cost rate.
FORM PAGE 7
Not applicable.
Progress reports to continue support of a PHS Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) Award must be submitted on PHS 2590 forms. The due date for these progress reports is determined by the awarding component. Grantees access a website to determine which progress reports are due. The Office of Policy for Extramural Research Administration, OER, National Institutes of Health (NIH) hosts the website located at: http://era.nih.gov/userreports/pr_due.cfm. Grantees are responsible for periodically checking the list, which is updated on/around the 30th of each month. In addition to this website, e-mail reminders are sent to the PI.
For grantee institutions and PD/PIs registered in the eRA Commons, the progress report due information is available in the Commons Status system. Commons-registered institutions and PD/PIs also have access to pre-populated face pages for the PHS 2590 Progress Report via Status. For more information on the Commons, see: https://commons.era.nih.gov/commons/index.jsp.
Additional information on this notification process can be found in the NIH Guide Notice OD-03-054: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-054.html.
Follow the instructions in Sections I and II of this document. This section contains additional instructions pertinent to Fast Track SBIR and STTR awards.
A Fast-Track Phase II application may be funded following submission of an original PHS 2590 Non-competing Continuation Progress Report. Follow the simplified instructions under the Streamlined Noncompeting Award Process (SNAP) found in Section 2.1 for all portions except the research plan, which should include the following:
1. A Phase I Final Progress Report: Follow the application instructions in the Grants.gov SBIR/STTR Application Guide SF424 (R&R), Section 5.4, Research Plan Component, Item 3, Research Strategy, Progress Report for Phase II and Phase II Competing Renewal and Revision Applications at http://grants.nih.gov/grants/funding/424/index.htm.
2. A section labeled Milestones (l) identifying either the milestones described in the original Phase I application as approved by the peer reviewers or the milestones modified by the peer reviewers and negotiated with the grantee; and (2) describing the progress achieved relative to the milestones.
3. A one-page abstract describing the research plan for Phase II. (See 2.2.6. D, "Plans" of the Progress Report Summary). If the aims have not been modified from the original Phase II application, state this. If they have been modified, give the reviewed aims and the reason for the modifications.
4. An updated Commercialization Plan as necessary, if changes have been made from the original submission.
Funding for the Phase II application will be contingent upon (1) assessment of the Phase I progress report and determination that the Phase I goals and milestones were achieved; (2) An update (as necessary) of the Commercialization Plan; (3) determination of the project's potential for meeting the mission of the awarding component and for commercial success; (4) review and approval of other documents necessary for continuation; and (5) availability of funds.
The eSNAP is due 45 days prior to the anticipated start of Phase II.
The appropriate grants management and program staff of the awarding component will review the Phase I Continuation Progress Report. If the continuation request is not approved, then written notification will be sent to the applicant.
A Phase II Final Progress Report is required to close out your Phase II grant.
You must submit a Final Report within 90 days of the project period end date. Submit the original report to the Central mailing address listed in Section 1 within 90 days of the termination of the grant.
Final reports serve as an important source of material for staff of the awarding component in preparing annual reports, for planning purposes, and in communicating scientific accomplishments achieved through the SBIR/STTR program.
There is no “form page” for a Final Report. It may be typed on plain white paper (or you may use the PHS 2590 Continuation Page). The recommended length for the narrative portion is 10 pages.
The format for the Phase II Final Progress Report is as follows:
1. State the beginning and end dates for the period covered by the SBIR/STTR Phase II grant.
2. Complete the All Personnel Report, listing the PD/PI(s) and all other personnel (salaried and unsalaried) for the current budget period who participated in the project during the current budget period for at least one person month or more, regardless of the source of compensation. A person month equals approximately 160 hours or 8.3% of annualized effort. Include the Commons ID (when applicable) names of individuals, all degrees, the last four digits of the Social Security number, role on project, date of birth (MM/YY), and number of person months devoted to the project (indicate academic, calendar, and/or summer).
When requesting the last four digits of the Social Security numbers from personnel, explain that provision of the Social Security number is voluntary, and the information will be used only for program management purposes. The Commons ID is required for all PD/PIs and all individuals with a postdoctoral role; it is optional for all other personnel.
Use the following categories for describing Role on Project:
PD/PI
Co-Investigator
Faculty Collaborator
Staff scientist (doctoral level)
Postdoctoral Scholar, Fellow, or Other Postdoctoral Position
Graduate Research Assistant
Undergraduate Research Assistant
Research Assistant/Coordinator
Technician
Consultant
Other (please specify)
3. Summarize the specific aims of the Phase II grant.
4. Provide a succinct account of published and unpublished results, indicating progress toward achievement of the originally stated aims. Include the Inclusion Enrollment Report with the final enrollment data for clinical research.
5. List titles and complete references to publications, and
manuscripts accepted for publication, if any, that resulted from the
Phase II.
When citing articles that fall under the
Public Access Policy, provide the NIH Manuscript Submission
reference number (e.g., NIHMS97531) or the PubMed Central (PMC)
reference number (e.g., PMCID234567) for each article. If the PMCID
is not yet available because the Journal submits articles directly
to PMC on behalf of their authors, indicate "PMC Journal - In
Process." A list of these Journals is posted at:
http://publicaccess.nih.gov/submit_process_journals.htm.
6. List patents, copyrights, trademarks, invention reports and other printed materials, if any, that resulted from the Phase II or describe patent status, trade secrets or other demonstration of IP protection.
7. Describe of the technology developed from this SBIR/STTR, its intended use and who will use it.
8. Describe the current status of the product (e.g., under development, commercialized, in use, discontinued).
9. If applicable, describe the status of FDA approval for your product, process, or service (e.g., continuing pre-IND studies, filed an IND, in Phase I (or II or III) clinical trials, applied for approval, review ongoing, approved, not approved, not ready to submit for FDA approval).
10. Describe how your company has benefited from the program and/or the technology developed (e.g., firm's growth, follow-on funding, increased technical expertise, licensing agreements, spin-off companies, public offering [include stock exchange and symbol]).
11. List of the generic and/or commercial name of product, process, or service, if any, that resulted from SBIR/STTR funding. If applicable, indicate the number of products sold.
12. Provide the current number of employees (total full time equivalents [FTEs]).
File Type | application/msword |
File Title | Non-Competing Grant Progress Report (PHS 2590) |
Subject | DHHS, Public Health Service, Non-Competing Grant Progress Report |
Author | Office of Extramural Programs |
Last Modified By | curriem |
File Modified | 2010-08-06 |
File Created | 2010-08-06 |